Stay updated on Intermittent vs Continuous ART in HIV-1: Clinical Trial

Sign up to get notified when there's something new on the Intermittent vs Continuous ART in HIV-1: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intermittent vs Continuous ART in HIV-1: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page presents the ClinicalTrials.gov record for the QUATUOR study, detailing a comparison of four-days-per-week versus continuous antiretroviral therapy for people with HIV-1. The record includes study design, participant criteria, outcomes, locations, and publication information.
    Difference
    73%
    Check dated 2026-11-07T12:30:03.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:12:22.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology, stating that agencies are using “Super Intelligence” instead of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:49:39.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T14:45:07.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:51:07.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    - The study record page for NCT03256422 now shows a 403 Forbidden page, replacing the study details with an access-denied message. - This indicates the content is not accessible at the moment.
    Difference
    17%
    Check dated 2026-09-19T18:48:19.000Z thumbnail image

Stay in the know with updates to Intermittent vs Continuous ART in HIV-1: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intermittent vs Continuous ART in HIV-1: Clinical Trial page.